Evaluating cost-effectiveness in the management of neuroendocrine neoplasms

por White, B. E., Mujica-Mota, R., Snowsill, T., Gamper, E. M., Srirajaskanthan, R., Ramage, J. K.
Publicado 2020

α-Fetoprotein and human chorionic gonadotrophin-β as prognostic markers in neuroendocrine tumour patients

por Shah, T, Srirajaskanthan, R, Bhogal, M, Toubanakis, C, Meyer, T, Noonan, A, Witney-Smith, C, Amin, T, Bhogal, P, Sivathasan, N, Warner, B, Hochhauser, D, Caplin, M E
Publicado 2008